These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 9316855)

  • 21. Dopamine D2-type agonists protect mesencephalic neurons from glutamate neurotoxicity: mechanisms of neuroprotective treatment against oxidative stress.
    Sawada H; Ibi M; Kihara T; Urushitani M; Akaike A; Kimura J; Shimohama S
    Ann Neurol; 1998 Jul; 44(1):110-9. PubMed ID: 9667598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of bromocriptine administration during the follicular phase of the oestrous cycle on prolactin and gonadotrophin secretion and follicular dynamics in merino monovular ewes.
    Picazo RA; González De Bulnes A; Gómez Brunet A; del Campo A; Granados B; Tresguerres J; López Sebastián A
    J Reprod Fertil; 2000 Sep; 120(1):177-86. PubMed ID: 11006160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of oestradiol-induced prolactin release in a dual-cannulated ovariectomized rat model by carmoxirole, a peripherally restricted dopamine agonist.
    Brott DA; Werkheiser JL; Campbell P; Bentley P; Andersson HH; Stewart J; Huby R; Altekar M; Kinter LB
    Basic Clin Pharmacol Toxicol; 2012 Dec; 111(6):411-6. PubMed ID: 22742711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silymarin BIO-C, an extract from Silybum marianum fruits, induces hyperprolactinemia in intact female rats.
    Capasso R; Aviello G; Capasso F; Savino F; Izzo AA; Lembo F; Borrelli F
    Phytomedicine; 2009 Sep; 16(9):839-44. PubMed ID: 19303749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Synergistic effect of bromocriptine combining tumor necrosis factor-alpha on reversing multidrug resistance in a nude mouse model of liver neoplasm].
    Ding L; Chen XP; Zhang ZW; Wang H; Cao B; Wang ZH; Li CL
    Zhonghua Wai Ke Za Zhi; 2005 Oct; 43(19):1248-53. PubMed ID: 16271222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicokinetics and biotransformation of 3-(4-methylbenzylidene)camphor in rats after oral administration.
    Völkel W; Colnot T; Schauer UM; Broschard TH; Dekant W
    Toxicol Appl Pharmacol; 2006 Oct; 216(2):331-8. PubMed ID: 16806338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.
    Li H; Shi S; Sun YH; Zhao YJ; Li QF; Li HZ; Wang R; Xu CQ
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):312-8. PubMed ID: 18986329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolactin inhibition at the end of lactation programs for a central hypothyroidism in adult rat.
    Bonomo IT; Lisboa PC; Passos MC; Alves SB; Reis AM; de Moura EG
    J Endocrinol; 2008 Aug; 198(2):331-7. PubMed ID: 18490438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of prolactin and bromocriptine on the population of prostate neuroendocrine cells from intact and cyproterone acetate-treated rats: stereological and immunohistochemical study.
    Ingelmo I; Gómez V; Martín R; Codesal J; Rodríguez R; Pozuelo JM; Santamaría L
    Anat Rec (Hoboken); 2007 Jul; 290(7):855-61. PubMed ID: 17541972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic-pharmacodynamic modeling of tolerance to the prolactin-secreting effect of chlorprothixene after different modes of drug administration.
    Bagli M; Süverkrüp R; Quadflieg R; Höflich G; Kasper S; Möller HJ; Langer M; Barlage U; Rao ML
    J Pharmacol Exp Ther; 1999 Nov; 291(2):547-54. PubMed ID: 10525070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
    Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
    Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of R-102444, an orally active 5-HT2A receptor antagonist, in rat models of peripheral vascular disease.
    Ogawa T; Sugidachi A; Tanaka N; Fujimoto K; Asai F
    Vascul Pharmacol; 2004 Feb; 41(1):7-13. PubMed ID: 15135326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term dysregulation of circadian and 17-beta estradiol-induced LH, prolactin and corticosterone secretion after dimethylbenz (a) anthracene administration in the Sprague-Dawley female rat.
    Yon de Jonage-Canonico MB; Lenoir V; Scholler R; Kerdelhué B
    Breast Cancer Res Treat; 2005 Jul; 92(1):47-50. PubMed ID: 15980990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bromocriptine, a dopamine D(2) receptor agonist with the structure of the amino acid ergot alkaloids, induces neurite outgrowth in PC12 cells.
    Oda T; Kume T; Izumi Y; Takada-Takatori Y; Niidome T; Akaike A
    Eur J Pharmacol; 2008 Nov; 598(1-3):27-31. PubMed ID: 18835264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of prolactin and bromocriptine administration on epididymal function--a biochemical study in rats.
    Reddy YD; Reddy KV; Govindappa S
    Indian J Physiol Pharmacol; 1985; 29(4):234-8. PubMed ID: 3842378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of prolactin secretion in rats with the ergoline derivative deprenon.
    Chlebounová J; Seda M; Fingerová H; Rezábek K
    Arzneimittelforschung; 1980; 30(6):956-8. PubMed ID: 7191272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The regulatory effect of bromocriptine on cardiac hypertrophy by prolactin and D2 receptor modulation.
    Aguayo-Cerón KA; Calzada-Mendoza CC; Méndez-Bolaina E; Romero-Nava R; Ocharan-Hernández ME
    Clin Exp Hypertens; 2020 Oct; 42(7):675-679. PubMed ID: 32478610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolactin suppression during pre and post-implantation periods on rat uterine glucosamine synthase activity.
    Vijayan E; Jayashree J
    Indian J Exp Biol; 1993 Apr; 31(4):386-8. PubMed ID: 8359840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Change of prolactin in SD rats with experimental autoimmune thyroiditis].
    Sun W; Song G; He B
    Zhonghua Nei Ke Za Zhi; 2001 Feb; 40(2):86-8. PubMed ID: 11798559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bromocriptine-induced dissociation of hyperglycemia and prolactin response to restraint.
    Ribeiro-de-Oliveira A; Guerra RM; Fóscolo RB; Marubayashi U; Reis AM; Coimbra CC
    Pharmacol Biochem Behav; 2001 Feb; 68(2):229-33. PubMed ID: 11267627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.